open access

Vol 81, No 4 (2022)
Review article
Submitted: 2021-08-08
Accepted: 2021-10-11
Published online: 2021-10-26
Get Citation

Factors causing variability in formation of coronary collaterals during coronary artery disease

S. Balakrishnan1, B. Senthil Kumar2
·
Pubmed: 34699051
·
Folia Morphol 2022;81(4):815-824.
Affiliations
  1. Department of Anatomy, Government Medical College, Institute of Integrated Medical Sciences, Palakkad, Kerala, India
  2. Department of Anatomy Vinayaka Mission’s Kirupananda Variyar Medical College, Vinayaka Missions Research Foundation (DU), Salem, Tamilnadu, India

open access

Vol 81, No 4 (2022)
REVIEW ARTICLES
Submitted: 2021-08-08
Accepted: 2021-10-11
Published online: 2021-10-26

Abstract

Coronary artery disease (CAD) is one of the major causes of death worldwide. CAD is narrowing of coronary arteries that prevents adequate blood supply to the heart muscle and results in acute coronary syndrome which includes unstable angina and myocardial infarction. The only remedy for it is to restore the perfusion through percutaneous intervention and grafting which may sometime cause reperfusion injury and other complications. Coronary collaterals are small inter-arterial connections that act as natural bypass which provide blood flow to the vascular territory, when the artery supplying to it gets obstructed. Acute collateral recruitment can occurs as a remedy for these adverse cardiac events. Various methods of therapies considered for the promotion and sustenance of functional coronary collaterals. The determinants of human coronary collaterals give clear evidence for prognosis in CAD and a new insight for further therapeutic promotion of coronary collaterals. This review mainly focuses on various studies done on coronary collaterals and the effect of various demographic, morphological and cardiovascular risk factors on the formation of coronary collaterals during obstructive CAD. Many studies have proven that various independent variables such as morphology of coronary artery, location of the lesion, duration of the occlusion, coronary dominance, biochemical factors, and cardiac risk factors, such as diabetes, hypertension, also affect collateral formation. The current update review gives a holistic view on coronary collaterals and findings of various authors on the effect of these independent variables on collateral formation.

Abstract

Coronary artery disease (CAD) is one of the major causes of death worldwide. CAD is narrowing of coronary arteries that prevents adequate blood supply to the heart muscle and results in acute coronary syndrome which includes unstable angina and myocardial infarction. The only remedy for it is to restore the perfusion through percutaneous intervention and grafting which may sometime cause reperfusion injury and other complications. Coronary collaterals are small inter-arterial connections that act as natural bypass which provide blood flow to the vascular territory, when the artery supplying to it gets obstructed. Acute collateral recruitment can occurs as a remedy for these adverse cardiac events. Various methods of therapies considered for the promotion and sustenance of functional coronary collaterals. The determinants of human coronary collaterals give clear evidence for prognosis in CAD and a new insight for further therapeutic promotion of coronary collaterals. This review mainly focuses on various studies done on coronary collaterals and the effect of various demographic, morphological and cardiovascular risk factors on the formation of coronary collaterals during obstructive CAD. Many studies have proven that various independent variables such as morphology of coronary artery, location of the lesion, duration of the occlusion, coronary dominance, biochemical factors, and cardiac risk factors, such as diabetes, hypertension, also affect collateral formation. The current update review gives a holistic view on coronary collaterals and findings of various authors on the effect of these independent variables on collateral formation.

Get Citation

Keywords

angiogenesis, arteriogenesis, percutaneous intervention, collateralisation, vascular endothelial growth factors, shear stress, oestrogen receptors

About this article
Title

Factors causing variability in formation of coronary collaterals during coronary artery disease

Journal

Folia Morphologica

Issue

Vol 81, No 4 (2022)

Article type

Review article

Pages

815-824

Published online

2021-10-26

Page views

4530

Article views/downloads

1285

DOI

10.5603/FM.a2021.0110

Pubmed

34699051

Bibliographic record

Folia Morphol 2022;81(4):815-824.

Keywords

angiogenesis
arteriogenesis
percutaneous intervention
collateralisation
vascular endothelial growth factors
shear stress
oestrogen receptors

Authors

S. Balakrishnan
B. Senthil Kumar

References (79)
  1. Abaci A, Oğuzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999; 99(17): 2239–2242.
  2. Adair TH, Montani JP. Angiogenesis. Morgan & Claypool Life Sciences:, San Rafael, CA 2010.
  3. Ajayi NO, Vanker EA, Satyapal KS. Coronary artery dominance dependent collateral development in the human heart. Folia Morphol. 2017; 76(2): 191–196.
  4. Altin C, Kanyilmaz S, Koc S, et al. Coronary anatomy, anatomic variations and anomalies: a retrospective coronary angiography study. Singapore Med J. 2015; 56(6): 339–345.
  5. Ansari Aval Z, Foroughi M. Impacts of established cardiovascular risk factors on the development of collateral circulation in chronic total occlusion of coronary arteries. Dis Markers. 2014; 1(3): 1011–1014.
  6. Banchi A. Morfologia della arteriae coronariae cordis. Arch Ital Anat Embriol. 1904; 3: 87–164.
  7. Baroldi G, Mantero O, Scomazzoni G. The collaterals of the coronary arteries in normal and pathologic hearts. Circ Res. 1956; 4(2): 223–229.
  8. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017; 135(10): 146–603.
  9. Buschmann EE, Brix M, Li L, et al. Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease. Vasa. 2016; 45(4): 317–324.
  10. Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J. 1993; 126(4): 937–945.
  11. Chien S. Mechanotransduction and Endothelial cell Homeostasis: The wisdom of cells. Am J Physiol Heart Circ Physiol. 2007; 292(3): H1209–H1224.
  12. Chigogidze M, Sharashidze N, Paghava Z. Gender differences in coronary collateral Circulation during acute and stable ischemic heart diseases. Translational and clinical Medicine. Georgian Med J Clin Med. 2018; 3: 25–31.
  13. Chilian WM, Mass HJ, Williams SE, et al. Microvascular occlusions promote coronary collateral growth. Am J Physiol Heart Circ Physiol. 1990; 258(4): H1103–H1111.
  14. Chilian WM, Penn MS, Pung YF, et al. Coronary collateral growth: back to the future. J Mol Cell Cardiol. 2012; 52(4): 905–911.
  15. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996; 271(30): 17629–17634.
  16. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986; 74(3): 469–476.
  17. Conway E, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3): 507–521.
  18. Dursun I, Bahcivan M, Durna K, et al. Treatment strategies in myocardial bridging: a case report. Cardiovasc Revasc Med. 2006; 7(3): 195–198.
  19. Elsman P, van 't Hof AWJ, de Boer MJ, et al. Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J. 2004; 25(10): 854–858.
  20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486–2497.
  21. Faber JE, Zhang H, Lassance Soares RM. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol. 2011; 31(8): 1748–1756.
  22. Frescura C, Basso C, Thiene G, et al. Anomalous origin of coronary arteries and risk of sudden death: A study based on an autopsy population of congenital heart disease. Hum Pathol. 1998; 29(7): 689–695.
  23. Fujita M, Nakae I, Kihara Y, et al. Determinants of Collateral Development in Patients with Acute Myocardial Infarction. Clin Cardiol. 1999; 22: 595–599.
  24. Fulton WF. Arterial anastomoses in the coronary circulation: I. Anatomical features in normal and diseased hearts demonstrated by stereo arteriography. Scott Med J. 1963; 8: 420–434.
  25. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991; 83(3): 739–746.
  26. Helfant RH, Kemp HG, Gorlin R, et al. Coronary atherosclerosis, coronary collaterals, and their relation to cardiac function. Ann Intern Med. 1970; 73(2): 189–193.
  27. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015; 116(4): 674–699.
  28. Hoefer IE, Van Royen N, Rectenwald JE, et al. Direct evidence for tumor necrosis factor-alpha signalling in Arteriogenesis. Circulation. 2002; 105(14): 1639–1641.
  29. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005; 45(10): 1638–1643.
  30. Huang A, Qi X, Cui Y, et al. Serum VEGF: diagnostic value of acute coronary syndrome from stable angina pectoris and prognostic value of coronary artery disease. Cardiol Res Pract. 2020; 2020: 6786302.
  31. Iorga A, Cunningham CM, Moazeni S, et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017; 8(1): 33.
  32. Ito WD, Arras M, Scholz D, et al. Schaper. Angiogenesis but not collateral growth is associated with Ischemia after femoral artery occlusion. Am J Physiol. 1997; 273(3 Pt. 2): H1255–H1265.
  33. Jamies TN. Anatomy of the coronary arteries. Paul B. Hoeber, New York 1961.
  34. Kayrak M, Ulgen MS, Ergene O, Kozan O. Textbook of Invasive cardiology, 1st ed. Hacettepe University Basımevi, Ankara 2007: 12–19.
  35. Koerselman J, de Jaegere PP, Verhaar MC, et al. SMART Study Group. High blood pressure is inversely related with the presence and extent of coronary collaterals. J Hum Hypertens. 2005; 19(10): 809–817.
  36. Koerselman J, de Jaegere PP, Verhaar M, et al. Coronary collateral circulation: The effects of smoking and alcohol. Atherosclerosis. 2007; 191(1): 191–198.
  37. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis. 2003; 14(1): 61–64.
  38. Kranz A, Rau G, Kochs M, et al. Elevation of vasculoendothelial growth factor: a serum level following acute Myocardial Infarction.Evidence for its origin and function significance . J Mol Cell Cardiol. 2000; 32(1): 65–72.
  39. Ladwiniec A, Hoye A. Coronary collaterals little give and take and a few unanswered questions. J Clin Exp Cardiol. 2013; 4(4): 2155–4172.
  40. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 1996; 94(5): 1074–1082.
  41. Lederman RJ, Mendelsohn FO, Anderson RD. Therapeutic angiogenesis with recombinant fibroblast growth factors-2 for intermittent claudication. Lancet. 2002; 359(9323): 2053–2058.
  42. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation. 1974; 50(4): 831–837.
  43. Mather KJ, Steinberg HO, Baron AD. Insulin resistance in the vasculature. J Clin Invest. 2013; 123(3): 1003–1004.
  44. Meier B, Rutishauser W. Coronary pacing during percutaneous transluminal coronary angioplasty. Circulation. 1985; 71(3): 557–561.
  45. Meier P, Gloekler S, de Marchi SF, et al. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial. Circulation. 2009; 120(14): 1355–1363.
  46. Melidonis A, Tournis S, Kouvaras G, et al. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol. 1999; 22(7): 465–471.
  47. Mittal N, Zhou Y, Linares C, et al. Analysis of blood flow in the entire coronary arterial tree. Am J Physiol Heart Circ Physiol. 2005; 289(1): H439–H446.
  48. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol. 2004; 24(3): e29–e50.
  49. Nickolay T, Nichols S, Ingle L, et al. Excercise training as a mediators for enhancing coronary collateral circulation :A review of the evidence. Curr Cardiol Rev. 2020; 16(3): 212–220.
  50. Niebauer J, Hambrecht R, Marburger C, et al. Impact of intensive physical exercise and low-fat diet on collateral vessel formation instable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol. 1995; 76(11): 771–775.
  51. Ommen SR, Gibbons RJ, Hodge DO, et al. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997; 79(6): 812–814.
  52. Patel B, Hopmann P, Desai M, et al. Coronary collateral growth: clinical perspectives and recent insights. Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy. 2017; 10: 5772–67164.
  53. Patel SR, Breall JA, Diver DJ, et al. Bradycardia is associated with development of coronary collateral vessels in humans. Coron Artery Dis. 2000; 11(6): 467–472.
  54. Piek JJ, van Liebergen RAM, Koch KT, et al. Comparison of collateral vascular responses in the donor and recipient coronary artery during transient coronary occlusion assessed by intracoronary blood flow velocity analysis in patients. J Am Coll Cardiol. 1997; 29(7): 1528–1535.
  55. Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993; 87(4): 1354–1367.
  56. Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. J Am Coll Cardiol. 2001; 38(7): 1872–1878.
  57. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985; 5(3): 587–592.
  58. Rentrop KP, Feit F, Sherman W, et al. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation. 1989; 80(5): 1166–1175.
  59. Richard S. Snell. Snell clinical anatomy. 7th ed. Lippincott Williams and Wilkins, Baltimore 2001.
  60. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. 2003; 23(7): 1143–1151.
  61. Schofield I, Mlik R, Izzard A, et al. Vascular structural and functional changes in type 2 diabetes mellitus. Circulation. 2002; 106(24): 3037–3043.
  62. Seiler C, Fleisch M, Garachemani A, et al. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol. 1998; 32(5): 1272–1279.
  63. Seiler C, Meier P. Historical aspects and relevance of the human coronary collateral circulation. Curr Cardiol Rev. 2014; 10(1): 2–16.
  64. Srinivasan MP, Kamath PK, Bhat NM, et al. Severity of coronary artery disease in type 2 diabetes mellitus: Does the timing matter? Indian Heart J. 2016; 68(2): 158–163.
  65. Standring S, Borley NR, Collins P, Crossman AR, Gatzoulis MA, Chealu J. Grays Anatomy. 40th ed. Churchill Livingstone Elsevier, China 2008.
  66. Tayebjee MH, Lip GYH, MacFadyen RJ. Is there an association between hypertension and the development of coronary collateral flow? J Hum Hypertens. 2005; 19: 757–759.
  67. Toor IS, Jaumdally R, Lip GYH, et al. Eosinophil count predicts mortality following percutaneous coronary intervention. Thromb Res. 2012; 130(4): 607–611.
  68. Verdoia M, Schaffer A, Cassetti E, et al. Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. J Thromb Thrombolysis. 2015; 39(4): 459–466.
  69. Villa ADM, Sammut E, Nair A, et al. Coronary artery anomalies overview: The normal and the abnormal. World J Radiol. 2016; 8(6): 537–555.
  70. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001; 49(3): 554–560.
  71. Walttenberger J, Lange J, Kranz A. Vasculoendothelial factors-A-Induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictors for the individual capacity to develop collaterals. Circulation. 2000; 102(2): 185–190.
  72. Wang J, Li Q, Li Sj, et al. Relationship of coronary collateral circulation with eosinophils in patients with unstable angina pectoris. Clin Interv Aging. 2016; 11: 105–110.
  73. Werner GS, Ferrari M, Heinke S, et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation. 2003; 107(15): 1972–1977.
  74. Wustmann K, Zbinden S, Windecker S, et al. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation. 2003; 107(17): 2213–2220.
  75. Xin Y, Wang Ym, Zhang H, et al. Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs. 2010; 34(3): 215–222.
  76. Yin L, Ohanyan V, Pung YF, et al. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ Res. 2012; 110(2): 241–252.
  77. Zbinden R, Zbinden S, Billinger M. Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart. 2005; 91(10): 1289–1293.
  78. Zimarino M, D'Andreamatteo M, Waksman R, et al. The dynamics of the coronary collateral circulation. Nat Rev Cardiol. 2014; 11(4): 191–197.
  79. Zoll PM, Wessler S, Schlesinger MJ. Interarterial coronary anastomoses in the human heart, with particular reference to anemia and relative cardiac anoxia. Circulation. 1951; 4(6): 797–815.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, faks: +48 58 320 94 60, e-mail: viamedica@viamedica.pl